736-12178-36214 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-31
Dose 1 — Pfizer-BioNTech
2021-04-23
Dose 2 — Pfizer-BioNTech
2021-12-16
Dose 3 — Pfizer-BioNTech
2021-12-29
Registered in v-safe
2021-12-29
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-30
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-06
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-15
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-20
Survey response — day 35, dose 3
MedDRA: Dry throat, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair

Free text: Congestion runny nose dry throat

MedDRA releases: 2024-11 · check-in free text available
2022-01-27
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-17
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-06-16
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-16
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-31	Pfizer-BioNTech	No
2	2021-04-23	Pfizer-BioNTech	No
3	2021-12-16	Pfizer-BioNTech	No

Free text

Release 10 — day 35, dose 3

2022-01-20

Symptoms: Congestion runny nose dry throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dry throat	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release